glp-1 news today nov 2025 November in review: breakthroughs, UPFs under fire, Novonesis advances healthy longevity Designing GLP-1 delivery: structural perspectives

THE PRODUCT MAY NOT BE USED AS A DRUG, AGRICULTURAL OR PESTICIDAL PRODUCT, FOOD ADDITIVE OR HOUSEHOLD CHEMICAL AND MAY NOT BE MISBRANDED AS SUCH

In patients converted to divalproex sodium monotherapy, the mean total valproate concentrations during monotherapy were 71 and 123 mcg/mL in the low dose and high dose groups, respectively

Most people are more comfortable taking a pill than regularly injecting themselves, says Daniel Drucker, an endocrinologist at the University of Toronto, who previously consulted for Novo Nordisk

While some view these medications as transformative advances that legitimize obesity as a treatable disease, others worry that their increasing popularity could undermine longstanding efforts to deconstruct diet culture and promote body positivity

You are eating less food overall

Kemenkes RI